These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35768556)

  • 61. Serum lipids and postprandial glucose and insulin levels in hyperlipidemic subjects after consumption of an oat beta-glucan-containing ready meal.
    Biörklund M; Holm J; Onning G
    Ann Nutr Metab; 2008; 52(2):83-90. PubMed ID: 18334815
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Arabinoxylan fiber, a byproduct of wheat flour processing, reduces the postprandial glucose response in normoglycemic subjects.
    Lu ZX; Walker KZ; Muir JG; Mascara T; O'Dea K
    Am J Clin Nutr; 2000 May; 71(5):1123-8. PubMed ID: 10799374
    [TBL] [Abstract][Full Text] [Related]  

  • 63. 24-h severe energy restriction impairs postprandial glycaemic control in young, lean males.
    Clayton DJ; Biddle J; Maher T; Funnell MP; Sargeant JA; King JA; Hulston CJ; Stensel DJ; James LJ
    Br J Nutr; 2018 Nov; 120(10):1107-1116. PubMed ID: 30401004
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of whey proteins on glycaemia and insulinaemia to an oral glucose load in healthy adults; a dose-response study.
    Gunnerud UJ; Ostman EM; Björck IM
    Eur J Clin Nutr; 2013 Jul; 67(7):749-53. PubMed ID: 23632747
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies.
    Calanna S; Christensen M; Holst JJ; Laferrère B; Gluud LL; Vilsbøll T; Knop FK
    Diabetologia; 2013 May; 56(5):965-72. PubMed ID: 23377698
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Beta-glucan from two sources of oat concentrates affect postprandial glycemia in relation to the level of viscosity.
    Panahi S; Ezatagha A; Temelli F; Vasanthan T; Vuksan V
    J Am Coll Nutr; 2007 Dec; 26(6):639-44. PubMed ID: 18187427
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials.
    Musso G; Gambino R; Cassader M; Paschetta E
    BMJ; 2019 Apr; 365():l1328. PubMed ID: 30967375
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A Double-Blind, Randomized Controlled, Acute Feeding Equivalence Trial of Small, Catalytic Doses of Fructose and Allulose on Postprandial Blood Glucose Metabolism in Healthy Participants: The Fructose and Allulose Catalytic Effects (FACE) Trial.
    Braunstein CR; Noronha JC; Glenn AJ; Viguiliouk E; Noseworthy R; Khan TA; Au-Yeung F; Blanco Mejia S; Wolever TMS; Josse RG; Kendall CWC; Sievenpiper JL
    Nutrients; 2018 Jun; 10(6):. PubMed ID: 29890724
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treatment of periodontal disease for glycaemic control in people with diabetes mellitus.
    Simpson TC; Weldon JC; Worthington HV; Needleman I; Wild SH; Moles DR; Stevenson B; Furness S; Iheozor-Ejiofor Z
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD004714. PubMed ID: 26545069
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Impact of insulin sensitivity, beta-cell function and glycaemic control on initiation of second-line glucose-lowering treatment in newly diagnosed type 2 diabetes.
    Rathmann W; Strassburger K; Bongaerts B; Bobrov P; Kuss O; Müssig K; Markgraf DF; Szendroedi J; Herder C; Roden M;
    Diabetes Obes Metab; 2017 Jun; 19(6):866-873. PubMed ID: 28127851
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An Oat β-Glucan Beverage Reduces LDL Cholesterol and Cardiovascular Disease Risk in Men and Women with Borderline High Cholesterol: A Double-Blind, Randomized, Controlled Clinical Trial.
    Ms Wolever T; Rahn M; Dioum E; Spruill SE; Ezatagha A; Campbell JE; Jenkins AL; Chu Y
    J Nutr; 2021 Sep; 151(9):2655-2666. PubMed ID: 34236436
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dietary fat and carbohydrate quality have independent effects on postprandial glucose and lipid responses.
    Sun L; Tan KWJ; Lim JZ; Magkos F; Henry CJ
    Eur J Nutr; 2018 Feb; 57(1):243-250. PubMed ID: 27770188
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of oat processing on the glycaemic and insulin responses in horses.
    Vervuert I; Coenen M; Bothe C
    J Anim Physiol Anim Nutr (Berl); 2003 Apr; 87(3-4):96-104. PubMed ID: 14511133
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Phytochemical Pharmacokinetics and Bioactivity of Oat and Barley Flour: A Randomized Crossover Trial.
    Sawicki CM; McKay DL; McKeown NM; Dallal G; Chen C-; Blumberg JB
    Nutrients; 2016 Dec; 8(12):. PubMed ID: 27983687
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A randomized crossover study to assess the effect of an oat-rich diet on glycaemic control, plasma lipids and postprandial glycaemia, inflammation and oxidative stress in Type 2 diabetes.
    McGeoch SC; Johnstone AM; Lobley GE; Adamson J; Hickson K; Holtrop G; Fyfe C; Clark LF; Pearson DW; Abraham P; Megson IL; MacRury SM
    Diabet Med; 2013 Nov; 30(11):1314-23. PubMed ID: 23668675
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis.
    George PS; Pearson ER; Witham MD
    Diabet Med; 2012 Aug; 29(8):e142-50. PubMed ID: 22486204
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Glycemic index and glycemic load used in combination to characterize metabolic responses of mixed meals in healthy lean young adults.
    Micha R; Nelson M
    J Am Coll Nutr; 2011 Apr; 30(2):113-25. PubMed ID: 21730219
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Depression of the glycemic index by high levels of beta-glucan fiber in two functional foods tested in type 2 diabetes.
    Jenkins AL; Jenkins DJ; Zdravkovic U; Würsch P; Vuksan V
    Eur J Clin Nutr; 2002 Jul; 56(7):622-8. PubMed ID: 12080401
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Oat β-glucan: physico-chemical characteristics in relation to its blood-glucose and cholesterol-lowering properties.
    Wang Q; Ellis PR
    Br J Nutr; 2014 Oct; 112 Suppl 2():S4-S13. PubMed ID: 25267243
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.